N Engl J Med. 2014 May 1;370(18):1683-93. doi: 10.1056/NEJMoa1401602. Epub 2014 Mar 18.
In a single-center study published more than a decade ago involving patients presenting to the emergency department with severe sepsis and septic shock, mortality was markedly lower among those who were treated according to a 6-hour protocol of early goal-directed therapy (EGDT), in which intravenous fluids, vasopressors, inotropes, and blood transfusions were adjusted to reach central hemodynamic targets, than among those receiving usual care. We conducted a trial to determine whether these findings were generalizable and whether all aspects of the protocol were necessary.
In 31 emergency departments in the United States, we randomly assigned patients with septic shock to one of three groups for 6 hours of resuscitation: protocol-based EGDT; protocol-based standard therapy that did not require the placement of a central venous catheter, administration of inotropes, or blood transfusions; or usual care. The primary end point was 60-day in-hospital mortality. We tested sequentially whether protocol-based care (EGDT and standard-therapy groups combined) was superior to usual care and whether protocol-based EGDT was superior to protocol-based standard therapy. Secondary outcomes included longer-term mortality and the need for organ support.
We enrolled 1341 patients, of whom 439 were randomly assigned to protocol-based EGDT, 446 to protocol-based standard therapy, and 456 to usual care. Resuscitation strategies differed significantly with respect to the monitoring of central venous pressure and oxygen and the use of intravenous fluids, vasopressors, inotropes, and blood transfusions. By 60 days, there were 92 deaths in the protocol-based EGDT group (21.0%), 81 in the protocol-based standard-therapy group (18.2%), and 86 in the usual-care group (18.9%) (relative risk with protocol-based therapy vs. usual care, 1.04; 95% confidence interval [CI], 0.82 to 1.31; P=0.83; relative risk with protocol-based EGDT vs. protocol-based standard therapy, 1.15; 95% CI, 0.88 to 1.51; P=0.31). There were no significant differences in 90-day mortality, 1-year mortality, or the need for organ support.
In a multicenter trial conducted in the tertiary care setting, protocol-based resuscitation of patients in whom septic shock was diagnosed in the emergency department did not improve outcomes. (Funded by the National Institute of General Medical Sciences; ProCESS ClinicalTrials.gov number, NCT00510835.).
在一项十多年前发表的单中心研究中,研究对象为因严重脓毒症和感染性休克而到急诊就诊的患者,结果显示,与接受常规治疗的患者相比,根据 6 小时早期目标导向治疗(EGDT)方案进行治疗的患者死亡率明显更低,在该方案中,静脉输液、血管加压药、正性肌力药和输血被调整以达到中心血流动力学目标。我们进行了一项试验,以确定这些发现是否具有普遍性,以及方案的所有方面是否都有必要。
在美国 31 家急诊室,我们将感染性休克患者随机分为三组进行 6 小时复苏:基于方案的 EGDT;不要求放置中心静脉导管、使用正性肌力药或输血的基于方案的标准治疗;或常规治疗。主要终点为 60 天院内死亡率。我们依次检验基于方案的治疗(EGDT 和标准治疗组合并)是否优于常规治疗,以及基于方案的 EGDT 是否优于基于方案的标准治疗。次要结局包括长期死亡率和器官支持需求。
我们纳入了 1341 名患者,其中 439 名被随机分配至基于方案的 EGDT 组,446 名被随机分配至基于方案的标准治疗组,456 名被随机分配至常规治疗组。在监测中心静脉压和氧饱和度以及使用静脉输液、血管加压药、正性肌力药和输血方面,复苏策略存在显著差异。在 60 天时,基于方案的 EGDT 组有 92 例死亡(21.0%),基于方案的标准治疗组有 81 例死亡(18.2%),常规治疗组有 86 例死亡(18.9%)(基于方案治疗与常规治疗的相对风险,1.04;95%置信区间[CI],0.82 至 1.31;P=0.83;基于方案的 EGDT 与基于方案的标准治疗的相对风险,1.15;95%CI,0.88 至 1.51;P=0.31)。90 天死亡率、1 年死亡率或器官支持需求无显著差异。
在一项三级保健机构开展的多中心试验中,对因急诊诊断为感染性休克的患者进行基于方案的复苏并不能改善结局。(由美国国立普通医学科学研究所资助;ProCESS 临床试验.gov 编号,NCT00510835。)